RECRUITING

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

Talk to us

Conditions

Infant, Extremely PrematureObstetric Labor, PrematurePremature BirthIntensive Care, NeonatalIntensive Care Units, Neonatal

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the Tiny Baby Collaborative Multicenter Inventory of Neonatal-Perinatal Interventions (MINI) minimum dataset is to serve as a registry detailing the outcomes and practices for all deliveries and infants admitted to intensive care at 22-23 weeks' gestation at participating hospitals.

Official Title

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

Quick Facts

Study Start:2019-01-01
Study Completion:2028-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05685745

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Years to 1 Year
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * All local births with gestational ages of 22 weeks 0 days - 23 weeks 6 days, regardless of pregnancy outcome or neonatal intensive care (NICU) admission; AND
  2. * All outborn NICU admissions with gestational age at birth of 22 weeks 0 days - 23 weeks 6 days
  3. * Optional: Centers who desire to include data for NICU admissions of infants born \<22 weeks' gestation may also submit these data.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Matthew A Rysavy, MD, PhD
CONTACT
713-500-5651
Matthew.A.Rysavy@uth.tmc.edu

Principal Investigator

Matthew A Rysavy, MD, PhD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35249
United States
University of Iowa
Iowa City, Iowa, 52242
United States
Duke University
Durham, North Carolina, 27708
United States
Nationwide Children's Hospital
Columbus, Ohio, 43205
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States
The Women's Hospital of Texas
Houston, Texas, 77054
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Matthew A Rysavy, MD, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-01-01
Study Completion Date2028-01-01

Study Record Updates

Study Start Date2019-01-01
Study Completion Date2028-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Infant, Extremely Premature
  • Obstetric Labor, Premature
  • Premature Birth
  • Intensive Care, Neonatal
  • Intensive Care Units, Neonatal